— Know what they know.
Not Investment Advice

EVFM OTC

Evofem Biosciences, Inc.
1W: -3.9% 1M: -7.5% 3M: -22.1% YTD: -22.1% 1Y: -44.8% 3Y: -94.7% 5Y: -100.0%
$0.01
+0.00 (+10.81%)
 
Weekly Expected Move ±7.8%
$0 $0 $0 $0 $0
OTC · Healthcare · Biotechnology · Tech Score Sell · Power 40 · $1.1M mcap · 133M float · 0.172% daily turnover · Short 15% of daily vol

📊 Key Metrics

TTM
$18M
Revenue
+4.5% YoY
$-15M
Net Income
-145.6% YoY
$-0M
Free Cash Flow
+90.9% YoY
80.1%
Gross Margin
-94.5%
Op. Margin
-419.1%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE20.1%
ROA-139.7%
ROIC26.0%

Valuation

P/E-0.1
P/B-0.0
EV/EBITDA-16.2

Leverage

Debt/Equity-0.83
Current Ratio0.07
Interest Cov.-6.8x

Quality Scores

Piotroski F2/9
Altman Z-182.94
Beneish M-12.81

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms